$79.00
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth hormone–releasing hormone (GHRH). It is widely referenced in neuroendocrine and peptide research focused on pituitary signaling and growth hormone regulatory pathways. Supplied strictly for laboratory research use only.
For research purposes only. Not for human consumption
Sermorelin, also known as GHRH(1–29), represents the biologically active fragment of endogenous growth hormone–releasing hormone responsible for stimulating pituitary somatotroph cells [1]. In molecular and preclinical research, sermorelin is used to study GHRH receptor activation, intracellular cyclic AMP signaling, and calcium-dependent pathways involved in growth hormone secretion [2]. Due to its shorter peptide length compared to full-length GHRH, sermorelin is often utilized in structure–activity relationship studies examining receptor binding efficiency and peptide stability [3].
In laboratory and animal research models, sermorelin is primarily studied in endocrinology, metabolism, and neuroendocrine research frameworks. Published literature explores its role in pulsatile growth hormone release, interactions with the growth hormone–insulin-like growth factor (GH–IGF) axis, and hypothalamic–pituitary signaling dynamics under controlled experimental conditions [4]. Additional investigations examine sermorelin in comparative studies with other GHRH analogs to evaluate receptor specificity and signaling duration [5][6]. These findings position sermorelin as a key reference peptide for researchers investigating growth hormone biology and peptide-based neuroendocrine regulation. This compound is not intended for human or veterinary use.
